FdaApplication
NDA 206353
Identifiers
- fda_app_no: NDA206353
Properties
| Property | Value |
|---|---|
| applicant_name | BRISTOL MYERS SQUIBB CO |
| application_type | NDA |
| approval_date | 2015-01-29 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| EVOTAZ | ATAZANAVIR SULFATE; COBICISTAT | EQ 300MG BASE;150MG | TABLET;ORAL |
1 product